Abstract
In the Original Article by Dikci et al. “The Association of Serum Vitamin D Levels with Pseudoexfoliation Glaucoma/ Syndrome” (Endocr Metab Immune Disord Drug Targets. 2019; 19(2):166-170) after publication of the article it has come to the corresponding author's attention that there were some errors in the article. In the introduction section, reference 3 should be changed as reference 2 (paragraph 1, line 4) and references 4-6 should be changed as references 3-6 (paragraph 1, lines 6,7). Reference numbers in the references section should be as follows. References 25-28 should be changed as references 7-10 respectively. References 7-24 should be changed as references 11-28 respectively.
Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:Corrigendum to: The Association of Serum Vitamin D Levels with Pseudoexfoliation Glaucoma/Syndrome
Volume: 19 Issue: 5
Author(s): Seyhan Dikci*, Emrah Öztürk, Penpe Gül Fırat, Turgut Yılmaz, Mehmet Çağatay Taşkapan and Saim Yoloğlu
Affiliation:
- Inonu Universiy Turgut Ozal Medical Center, Department of Ophthalmology, Malatya,Turkey
Abstract: In the Original Article by Dikci et al. “The Association of Serum Vitamin D Levels with Pseudoexfoliation Glaucoma/ Syndrome” (Endocr Metab Immune Disord Drug Targets. 2019; 19(2):166-170) after publication of the article it has come to the corresponding author's attention that there were some errors in the article. In the introduction section, reference 3 should be changed as reference 2 (paragraph 1, line 4) and references 4-6 should be changed as references 3-6 (paragraph 1, lines 6,7). Reference numbers in the references section should be as follows. References 25-28 should be changed as references 7-10 respectively. References 7-24 should be changed as references 11-28 respectively.
Export Options
About this article
Cite this article as:
Dikci Seyhan *, Öztürk Emrah , Fırat Gül Penpe , Yılmaz Turgut , Taşkapan Çağatay Mehmet and Yoloğlu Saim , Corrigendum to: The Association of Serum Vitamin D Levels with Pseudoexfoliation Glaucoma/Syndrome, Endocrine, Metabolic & Immune Disorders - Drug Targets 2019; 19 (5) . https://dx.doi.org/10.2174/187153031905190701170237
DOI https://dx.doi.org/10.2174/187153031905190701170237 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Evaluating Quinacrine as a Potential Amyloid Imaging Compound: Studies on Hen Egg White Lysozyme as Model System
Protein & Peptide Letters Chemical Constituents and Biological Activities of Cordia myxa L.: A Review
The Natural Products Journal Differential Splicing, Disease and Drug Targets
Infectious Disorders - Drug Targets Medical Gains of Chondroitin Sulfate Upon Fucosylation
Current Medicinal Chemistry The Roles of Vitamin D and Its Analogs in Inflammatory Diseases
Current Topics in Medicinal Chemistry Novel Optical Techniques for Imaging Microcirculation in the Diabetic Foot
Current Pharmaceutical Design Anticancer Therapeutic Strategies Based on CDK Inhibitors
Current Pharmaceutical Design Targeting Apoptosis Resistance in Rhabdomyosarcoma
Current Cancer Drug Targets Kinetics, Role and Therapeutic Implications of Endogenous Soluble form of Receptor for Advanced Glycation end Products (sRAGE) in Diabetes
Current Drug Targets AIDS-related Insulin Resistance and Lipodystrophy Syndrome
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Targeting Dyslipidemia in the Metabolic Syndrome: An Update
Current Vascular Pharmacology Recent Advancements in Pharmacological Stent Therapy Using Polymeric Materials: Opportunities and Challenges
Current Drug Delivery Side Effects of AAS Abuse: An Overview
Mini-Reviews in Medicinal Chemistry New Horizons in Diabetes Therapy: The Angiogenesis Paradox in Diabetes: Description of the Problem and Presentation of a Unifying Hypothesis
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Pharmacogenetics of Glucagon-like Peptide-1 Agonists for the Treatment of Type 2 Diabetes Mellitus
Current Clinical Pharmacology Adjuvant Hormonal Therapy in Women with Early-stage Breast Cancer
Medicinal Chemistry Metformin and Inflammation: Its Potential Beyond Glucose-lowering Effect
Endocrine, Metabolic & Immune Disorders - Drug Targets Biologic Agents for Treatment of Rheumatoid Arthritis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Antineoplastic Action of Growth Hormone-Releasing Hormone (GHRH) Antagonists
Recent Patents on Anti-Cancer Drug Discovery Protein Kinase C-theta Inhibitors: A Novel Therapy for Inflammatory Disorders
Current Pharmaceutical Design